IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination

FEBS Journal

Volumn 283, Issue 1, 2016, Pages 9-24

  Oleszycka, Ewa ^a   Moran, Hannah B T ^a   Tynan, Graham A ^a   Hearnden, Claire H ^a   Coutts, Graham ^b   Campbell, Matthew ^a   Allan, Stuart M ^b   Scott, Christopher J ^c   Lavelle, Ed C ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

aluminium adjuvant; cathepsin S; IL 1; inflammasome

Indexed keywords

ALUMINUM HYDROXIDE; CATHEPSIN S; CRYOPYRIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G2C; INFLAMMASOME; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG; ALUMINUM POTASSIUM SULFATE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; VACCINATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE;

ALUM COMPOUNDS; ANIMALS; INFLAMMASOMES; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; VACCINATION;

EID: 84954395099     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13546     Document Type: Article

References (39)

1. Dinarello CA, Simon A, &, van der Meer JW, (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11, 633-652.
2. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, &, Aunins J, (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
3. Sutterwala FS, Ogura Y, &, Flavell RA, (2007) The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 82, 259-264.
4. Leemans JC, Cassel SL, &, Sutterwala FS, (2011) Sensing damage by the NLRP3 inflammasome. Immunol Rev 243, 152-162.
5. Martinon F, Pétrilli V, Mayor A, Tardivel A, &, Tschopp J, (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
6. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, et al,. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
7. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, &, Golenbock DT, (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9, 857-865.
8. Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al,. (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11, 395-402.
9. Lindblad EB, (2004) Aluminium compounds for use in vaccines. Immunol Cell Biol 82, 497-505.
10. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, &, Flavell RA, (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-U13.
11. Kool M, Pétrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, &, Tschopp J, (2008) Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 181, 3755-3759.
12. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Petrilli V, Tschopp J, et al,. (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 106, 870-875.
13. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, &, Latz E, (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9, 847-856.
14. Jacobson LS, Lima H, Goldberg MF, Gocheva V, Tsiperson V, Sutterwala FS, Joyce JA, Gapp BV, Blomen VA, Chandran K, et al,. (2013) Cathepsin-mediated necrosis controls the adaptive immune response by Th2 (T helper type 2)-associated adjuvants. J Biol Chem 288, 7481-7491.
15. McKee AS, Munks MW, MacLeod MKL, Fleenor CJ, Van Rooijen N, Kappler JW, &, Marrack P, (2009) Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183, 4403-4414.
16. Kool M, Soullie T, van Nimwegen M, Willart MAM, Muskens F, Jung S, Hoogsteden HC, Hammad H, &, Lambrecht BN, (2008) Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 205, 869-882.
17. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, &, Nemazee D, (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314, 1936-1938.
18. Li H, Willingham SB, Ting JP, &, Re F, (2008) Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 181, 17-21.
19. Seubert A, Calabro S, Santini L, Galli B, Genovese A, Valentini S, Aprea S, Colaprico A, D'Oro U, Giuliani MM, et al,. (2011) Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. Proc Natl Acad Sci USA 108, 11169-11174.
20. Li HF, Nookala S, &, Re F, (2007) Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1 beta and IL-18 release. J Immunol 178, 5271-5276.
21. MacLeod MKL, McKee AS, David A, Wang J, Mason R, Kappler JW, &, Marrack P, (2011) Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. Proc Natl Acad Sci USA 108, 7914-7919.
22. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, et al,. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11, 897-904.
23. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, &, Sutterwala FS, (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105, 9035-9040.
24. Schroder K, &, Tschopp J, (2010) The Inflammasomes. Cell 140, 821-832.
25. Yang M, Hearnden CH, Oleszycka E, &, Lavelle EC, (2013) NLRP3 inflammasome activation and cytotoxicity induced by particulate adjuvants. Methods Mol Biol 1040, 41-63.
26. Franchi L, &, Nunez G, (2008) The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1 beta secretion but dispensable for adjuvant activity. Eur J Immunol 38, 2085-2089.
27. Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, Lekeux P, Coban C, Akira S, Ishii KJ, et al,. (2011) DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17, 996-1002.
28. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, &, Rock KL, (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13, 851-856.
29. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, &, Apte RN, (2011) IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187, 4835-4843.
30. Tynan GA, Hearnden CH, Oleszycka E, Lyons CL, Coutts G, O'Connell J, Corrigan MA, Lynch L, Campbell M, Callanan JJ, et al,. (2014) Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation. Diabetes 63, 2037-2050.
31. Ellebedy AH, Lupfer C, Ghoneim HE, DeBeauchamp J, Kanneganti TD, &, Webby RJ, (2011) Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci USA 108, 2927-2932.
32. Kono H, Orlowski GM, Patel Z, &, Rock KL, (2012) The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C. J Immunol 189, 3734-3740.
33. Lützner N, &, Kalbacher H, (2008) Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate. J Biol Chem 283, 36185-36194.
34. Välimäki E, Miettinen JJ, Lietzén N, Matikainen S, &, Nyman TA, (2013) Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages. Mol Cell Proteomics 12, 749-763.
35. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, &, Cheronis J, (1999) Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 96, 6261-6266.
36. Hazuda DJ, Strickler J, Kueppers F, Simon PL, &, Young PR, (1990) Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem 265, 6318-6322.
37. Bossaller L, Chiang PI, Schmidt-Lauber C, Ganesan S, Kaiser WJ, Rathinam VA, Mocarski ES, Subramanian D, Green DR, Silverman N, et al,. (2012) Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol 189, 5508-5512.
38. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekhout T, &, Geijtenbeek TB, (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat Immunol 13, 246-254.
39. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, &, Schuler G, (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223, 77-92.